Discontinued — last reported Q3 '25
Biotechnology — Depreciation and amortization of intangible assets
Danaher Biotechnology — Depreciation and amortization of intangible assets remained flat by 0.0% to $38.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.6%, from $36.00M to $38.00M. Over 3 years (FY 2021 to FY 2024), Biotechnology — Depreciation and amortization of intangible assets shows a downward trend with a -47.8% CAGR.
Analysis
How to read this metric
An increase often reflects significant recent capital investment or the amortization of newly acquired intangible assets, whereas a decrease may suggest aging assets or a reduction in acquisition-related intangible write-offs.
Detailed definition
This metric aggregates the non-cash charges related to the systematic allocation of the cost of tangible fixed assets an...
Peer comparison
Comparable to segment-level depreciation and amortization (D&A) reported by capital-intensive manufacturing and life science companies.
dhr_segment_biotechnology_depreciation_and_amortization_of_intangible_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $264.75M | $264.75M | $264.75M | $250.50M | $250.50M | $250.50M | $250.50M | $256.50M | $256.50M | $256.50M | $256.50M | $42.00M | $35.00M | $36.00M | $38.00M | $34.00M | $38.00M | $38.00M |
| QoQ Change | — | +0.0% | +0.0% | -5.4% | +0.0% | +0.0% | +0.0% | +2.4% | +0.0% | +0.0% | +0.0% | -83.6% | -16.7% | +2.9% | +5.6% | -10.5% | +11.8% | +0.0% |
| YoY Change | — | — | — | — | -5.4% | -5.4% | -5.4% | +2.4% | +2.4% | +2.4% | +2.4% | -83.6% | -86.4% | -86.0% | -85.2% | -19.0% | +8.6% | +5.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — depreciation and amortization of intangible assets?
- Danaher (DHR) reported biotechnology — depreciation and amortization of intangible assets of $38.00M in Q3 2025.
- How has Danaher's biotechnology — depreciation and amortization of intangible assets changed year-over-year?
- Danaher's biotechnology — depreciation and amortization of intangible assets increased by 5.6% year-over-year, from $36.00M to $38.00M.
- What is the long-term trend for Danaher's biotechnology — depreciation and amortization of intangible assets?
- Over 3 years (2021 to 2024), Danaher's biotechnology — depreciation and amortization of intangible assets has grown at a -47.8% compound annual growth rate (CAGR), from $1.06B to $151.00M.
- What does biotechnology — depreciation and amortization of intangible assets mean?
- The total non-cash expense for the wear and tear of physical equipment and the gradual write-off of acquired intangible assets in the biotechnology segment.